Alkermes Plc - ALKS - Stock Price & News | The Motley Fool
Alkermes' Q3 Proprietary Sales Soar 18% The biopharma company's third-quarter report highlighted robust proprietary product performance, despite some weakness relating to its …
OFF
Alkermes Plc - ALKS - Stock Price & News | The Motley Fool
1 week from now
Alkermes' Q3 Proprietary Sales Soar 18% The biopharma company's third-quarter report highlighted robust proprietary product performance, despite some weakness relating to its …
fool.com
OFF
Alkermes Makes Financial Progress As Its Pipeline Moves Forward
1 week from now
Oct 24, 2018 · Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. ... Alkermes' Q3 Proprietary Sales Soar 18%. …
fool.com
OFF
Why Alkermes Stock Is Sinking Today | The Motley Fool
1 week from now
Oct 25, 2023 · The Motley Fool recommends Alkermes Plc. The Motley Fool has a disclosure policy. Related Articles. Alkermes' Q3 Proprietary Sales Soar 18%. Alkermes (ALKS) Q2 2022 …
fool.com
OFF
Alkermes Plc Reports Third Quarter 2024 Financial Results - Yahoo …
1 week from now
Thu, Oct 24, 2024, 7:00 AM 17 min read. In This Article: ALKS. — Third Quarter Revenues of $378.1 Million —. — Net Sales of Proprietary Products Increased Approximately 18% Year …
yahoo.com
OFF
Alkermes PLC (ALKS) Q3 2024 Earnings Call Highlights: Strong ...
1 week from now
Oct 25, 2024 · In This Article: ALKS. Total Revenue: $378.1 million for Q3 2024. Proprietary Product Portfolio Growth: 18% year-over-year. Vivitrol Net Sales: $113.7 million, 14% year …
yahoo.com
OFF
ALKS News Today | Why Did Alkermes Stock Go Down Today?
1 week from now
Nov 7, 2024 · Alkermes' Q3 Proprietary Sales Soar 18%. October 26, 2024 | fool.com. Alkermes PLC (ALKS) Q3 2024 Earnings Call Highlights: Strong Proprietary Product Growth and ...
marketbeat.com
OFF
Alkermes (ALKS) Reports Q3 Earnings: What Key Metrics Have To Say
1 week from now
Oct 24, 2024 · ALKS. Alkermes (ALKS) reported $378.14 million in revenue for the quarter ended September 2024, representing a year-over-year decline of 0.7%. EPS of $0.73 for the same …
yahoo.com
OFF
Alkermes' Q3 Proprietary Sales Soar 18% - Longportapp.com
1 week from now
Oct 24, 2024 · Alkermes reported an 18% increase in proprietary product sales for Q3 2024, reaching $100 million, despite a slight overall revenue decline to $123.1 million. The company …
longportapp.com
OFF
Alkermes Inc.: Strong Q3 Performance And Strategic Growth Drive …
1 week from now
Oct 27, 2024 · The company was founded on May 4, 2011 and is headquartered in Dublin, Ireland. Read More on ALKS: Alkermes price target lowered to $28 from $29 at BofA. …
businessinsider.com
OFF
Alkermes (ALKS) Q3 Earnings On The Horizon: Analysts' Insights
1 week from now
Oct 22, 2024 · In its upcoming report, Alkermes (ALKS) is predicted by Wall Street analysts to post quarterly earnings of $0.80 per share, reflecting an increase of 25% compared to the …
nasdaq.com
OFF
Why Shares Of Alkermes Rose 18% Last Month | The Motley Fool
1 week from now
May 7, 2021 · Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More Why Shares …
fool.com
OFF
ALKS Stock Price - Alkermes Plc Stock Candlestick Chart
1 week from now
Alkermes' Q3 Proprietary Sales Soar 18% - The Motley Fool Oct 24, 2024. Oct 24, 2024. Alkermes (NASDAQ:ALKS) Shares Gap DownHere's Why - MarketBeat Oct 24, 2024. Oct 24, …
stockscan.io
OFF
Realty Income (O) Q3 2024 Earnings Call Transcript - The Motley …
1 week from now
Nov 5, 2024 · O earnings call for the period ending September 30, 2024. Image source: The Motley Fool. Realty Income (O -1.09%) Q3 2024 Earnings Call. Nov 05, 2024, 2:00 p.m. ET.
fool.com
OFF
Why Alkermes Stock Blasted 15% Higher Today | The Motley Fool
1 week from now
Feb 16, 2022 · So what. For its final quarter of 2021, Alkermes posted revenue of $324.5 million. This was a sturdy 16% higher than in the same period the previous year. Non- GAAP …
fool.com
OFF
Axsome Delivers Strong Q3 Revenue Beat | The Motley Fool
1 week from now
3 days ago · Key Points. Axsome Therapeutics' revenue for Q3 jumped to $104.8 million, up 81% year over year. The net loss per share was $1.34, slightly better than the expected loss of …
fool.com
OFF
3 Top Bank Stocks To Buy In May | The Motley Fool
1 week from now
May 4, 2023 · Here are three bank stocks to buy in May. 1. Wells Fargo. Large bank Wells Fargo (WFC 0.89%) is actually only down about 5% this year, which is pretty good all things …
fool.com
FAQs about Alkermes Plc - ALKS - Stock Price & News | The Motley Fool Coupon?
Is Alkermes Plc a good stock to buy?
How did Alkermes perform in Q1?
How did Alkermes perform in third-quarter 2024?
What happened to Alkermes shares?
Where is Alkermes plc headquartered?
Should Keith Speights buy Alkermes plc (Alkermes)?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
